Some data “doodling” on the impact of the experimental C19 mRNA injections on case rates for six countries

Using data from the two links below, I have constructed tables that should provide a few clues. The data is, of course, subject to all sorts of caveats around the inappropriate number of amplification cycles used in RT-PCR tests and incorrect classification “death with C19 present”, rather than “cause of death”.

COVID Live - Coronavirus Statistics - Worldometer (worldometers.info)

Coronavirus (COVID-19) Vaccinations - Our World in Data

Countries imposed or attempted to impose a whole range of measures to control and monitor the pandemic – from the most draconian lockdown measures to frequent testing, whilst banning all other treatment protocols with emerging and compelling track records in preventing infections and curing early to mid-stage C19 disease symptoms.

When experimental C19 mRNA injections became available, the politicians and medical advisors in all developed countries inflicted some of the most egregious breaches of every human rights convention ever written, to force their people to engage in an untested and unproven experimental treatment protocol.

All countries failed to verify (audit) the Phase 3 clinical trials of the manufacturers, failed to check and understand the specified end points of the clinical trials, failed to notice the increase in adverse events predicted by the clinical trials (that were the sole specified end point of the trials) and failed to notice the poor manufacturing quality of the contents of the doses within the vials as billions of vials were produced for global injections.

Instead governments and their top medical experts, pursued the experiment THAT FAILED CLINICAL TRIALS and inflicted the injection of toxins on their people.

Here is a table of the uptake of injections at six month intervals since their launch in December 2020 in a sample of countries.

Note this is the dosage expressed as number of doses per capita for the total population, not the population eligible for injections.

From the table, you can see that whilst Australia and New Zealand lagged behind the other countries uptake of injections during 2021, by mid-2022 it had more than caught up and is now at the same initial series + booster dosage level (Australia) or higher dosage than all others, in the case of New Zealand.

Note: the case rate is determined using RT-PCR tests (at more than the limit for producing accurate results of 27 amplification cycles) or Rapid Antigen Tests confirmed by RT-PCR tests.

Cases before injections - during 2020 and with partial uptake to a single dose per capita in 2021

Here is the “BEFORE FULL SERIES OF INJECTIONS” number of cases - prior to 31 December 2021, that is, over the period of no C19 injections in 2020 and the uptake to 1 dose per capita over 2021:

Cases per million for Australia and New Zealand were far below those elsewhere, all the way up to December 2021. New Zealand and Australia C19 lockdown measures ranked amongst the most draconian in the world. Denmark tested its population more than anyone at 14 times per capita (v 3 times per capita for Australia, 1.5 times per capita for New Zealand, UK 7.5 times, US 3.5 times per capita, over the duration of the pandemic).

The same very low comparative numbers for cases for New Zealand and Australia, applies to deaths with C19 present (see below) in New Zealand and Australia.

Note that, for those that succumbed with C19 present, NZ and Australia probably had the same incidence of 2-6 co-morbidities present at time of death as the other countries and, similarly, those that succumbed had probably lived 1-2 years longer than population life expectancy.

Cases after initial series of injections by end 2021 and with boosters in 2022

Here are the case rates from the end of December 2021 when all countries had more or less completed the initial series of (2) doses on a per capita basis and were increasingly boosted over 2022.

Case rates per million for Australia and New Zealand over the full period of the pandemic are now in between those of the US and UK and those of Germany and Denmark. Australia and New Zealand are broadly in the same place in terms of cases per million as other countries. Asian countries (especially South Korea) have experienced the same, or worse, increase in cases per million as Australia and New Zealand over 2022.

Note the UK ended ALL C19 restrictions by 14 March 2022 and has the smallest increase from 30 June 2022to the present time, in cases per million (16,739) of all countries in the table.

Denmark’s cases per million are up the second least in the table of countries, at around +21,000. It lifted the last of its C19 restrictions on 29 March 2022.

Australia’s cases per million since the end of June 2022 are up around 87,000 per million and NZ’s are up by almost 100,000 per million) over the same (3.5 month) period.

Germany’s cases per million are up around 85,000 in the last 3.5 months.

Compare the case rates per million of these countries for the year with “no injections”, to the gradual uptake in doses to the “initial series dosage” over 2021 and the last, “fully dosed and mostly boosted”, case rate so far in 2022.

US C19 case rate was 6% for 2020, it increased by 10% over 2021 and has increased at 14% so far over 2022.

Australia case rate was 0.1% for 2020, increased by 15.0% over 2021 and has increased by 25% so far over 2022.

New Zealand case rate was 0.4% for 2020, increased by 2.4% over 2021 and increased by 34% so far over 2022.

C19 Mortality Rates

Here is a table of fatalities for 6 month periods, for the 2020 year with no injections and the 2021 year with partial (one dose per capita) injections.

Compared to other countries, Australia and New Zealand suffered a fraction of the deaths per million.

Leaving aside the adverse events from the C19 injections here is what happened when populations were fully dosed and progressively boosted.

And here’s the data so far over 2022, post the completion of the initial series per capita by end December 2021 plus increasing booster doses per capita over 2022.

Although deaths per million in the northern hemisphere are far higher and the rate of increase in deaths per million is lower for Australia and New Zealand over the course of 2022 so far, the deaths per million over the (almost) three years of the pandemic, have increased from 90 per million at the end of 2021 for Australia to almost 600 per million. Deaths per million for New Zealand have increased by more than 600 per million from 12 per million to 617 per million.

What conclusions can we draw from this?

Well not many! Hey, it’s a data doodle!

Here’s a few observations and conjectures.

C19 injections are completely ineffective in reducing “cases” of infections from the Omicron variant (which emerged at the end of December 2021).

All of the gains in lower infection rates in New Zealand and Australia over two years (after some of the harshest lockdown measures over the first two years of the pandemic on the planet) have vanished over 2022.  Significantly lower mortality rates for Australia and New Zealand over the first two years of the pandemic are also rapidly being lost. Not yet worse than northern hemisphere countries, but then all these countries could have obliterated the pandemic in a few months had they used IVM and HCQ protocols as prophylactics and treatments for C19. Just as the Indian state of Uttar Pradesh did for its 240 million people.

Onwards!